Navigation Links
Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism

The thyroid hormone replacement prescription drug, levothyroxine sodium (Unithroid) for hypothyroidism in adults and children has been approved for use in the United States by the FDA.

The thyroid hormaone is involved in the regulation of a wide range of metabolic processes within the body in all age groups. In children thyroid hormones are essential for normal physical growth and intellectual development.

Low levels of thyroid hormone or hypothyroidism may be due to a birth defect for examole partial or complete absence of the thyroid gland or it may occur later in life due in conditions such as thyroiditis, goiter, or on surgical removal of the thyroid gland.

Other or previously-used medications, such as Synthroid, Cytomel, Euthyroid, Thyrolar, and Armour Thyroid, are often difficult to control, and sometimes results in symptoms of hyperthyroidism.

Levothyroxine sodium (Unithroid) is identical to a natural thyroid hormone produced by the body.

During initiation of replacement therapy with levothyroxine, blood tests are usually performed every six to eight weeks in adults to aid in dose adjustment. Once the optimal replacement dose of levothryoxine for an individual adult patient is determined, blood tests are usually done less frequently; e.g., every six to twelve months.

Symptoms of hypothyroidism include poor growth in children and, in those born with this disorder, impaired intellectual development if this disorder is not promptly and adequately treated. Symptoms of hypothyroidism in children and adults include fatigue, cold intolerance, dry skin, lethargy and weight gain.
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Another Cause of Thyroid Cancer Discovered
3. Common Thyroid Problems In Women May Lower Their Risk Of Developing Breast Cancer
4. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
5. Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region
6. Endoscopic Thyroidectomy Helps In Removing Thyroid Cysts
7. Differentiated Thyroid Carcinoma Can Widely Infiltrate The Larynx
8. Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine
9. New Study Suggests Perchlorate Effects on Thyroid Function of U.S. Women
10. Levels of Thyroid Hormone Forecasts Life Span
11. Longer-Lived Rodents Have Lower Levels of Thyroid Hormone
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology: